Swissbiotech Domain Overview🔒 SSL Verified

Official Contact & Profiles

Visual representation extracted from swissbiotech.org

Content Snippets from swissbiotech.org

"Total revenues reached a record CHF 7.5 billion in 2025 (CHF 7.2 billion in 2024) with more companies maturing to the commercial stage and a continuously growing demand for specialized CDMO services. Funding increased by 2.1% to CHF 2.6 billion. In a notable shift, investments in privately funded companies achieved a record CHF 1.15 billion – an increase of 38% compared to 2024, and a record 45%"

"We track and escalate fraud campaigns that target Swiss Biotech Association members and Swiss Biotech Day participants. Current campaigns are listed in the box above and updated as new ones appear. The guidance below applies to all of them. Please read it carefully and share it within your organization."

"NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury — Round Led by Neurimmune and Pureos, with Participation from Existing and New Investors, Complemented by Non-Dilutive Funding from the Swiss Paraplegic Foundation and Wings for Life – Spinal Cord Research Foundation"

"Collaboration will use NewBiologix’s Xcell platform to establish a scalable manufacturing foundation for Synastra’s investigational DMD gene therapy program."